Publication: The utility of biomarkers in traumatic brain injury clinical management.
| dc.contributor.author | Rodriguez-Rodriguez, Ana | |
| dc.contributor.author | Egea-Guerrero, Juan Jose | |
| dc.date.accessioned | 2023-01-25T09:42:21Z | |
| dc.date.available | 2023-01-25T09:42:21Z | |
| dc.date.issued | 2016-11-18 | |
| dc.description.abstract | We read the article by Thelin et al. entitled “Utility of neuron-specific enolase in traumatic brain injury; relations to S100B levels, outcome, and extracranial injury severity” [1] with great interest. The authors conclude that while S100B and neuron-specific enolase (NSE) are both biomarkers for long-term outcome, S100B is a more accurate predictor. | |
| dc.description.version | Si | |
| dc.identifier.citation | Rodríguez-Rodríguez A, Egea-Guerrero JJ. The utility of biomarkers in traumatic brain injury clinical management. Crit Care. 2016 Nov 18;20(1):376. | |
| dc.identifier.doi | 10.1186/s13054-016-1545-5 | |
| dc.identifier.essn | 1466-609X | |
| dc.identifier.pmc | PMC5114747 | |
| dc.identifier.pmid | 27855696 | |
| dc.identifier.pubmedURL | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5114747/pdf | |
| dc.identifier.unpaywallURL | https://doi.org/10.1186/s13054-016-1545-5 | |
| dc.identifier.uri | http://hdl.handle.net/10668/10612 | |
| dc.issue.number | 1 | |
| dc.journal.title | Critical care (London, England) | |
| dc.journal.titleabbreviation | Crit Care | |
| dc.language.iso | en | |
| dc.organization | Instituto de Biomedicina de Sevilla-IBIS | |
| dc.organization | Hospital Universitario Virgen del Rocío | |
| dc.page.number | 2 | |
| dc.provenance | Realizada la curación de contenido 24/07/2025. | |
| dc.publisher | BioMed Central Ltd. | |
| dc.pubmedtype | Letter | |
| dc.pubmedtype | Comment | |
| dc.relation.publisherversion | https://ccforum.biomedcentral.com/articles/10.1186/s13054-016-1545-5 | |
| dc.rights | Attribution 4.0 International | |
| dc.rights.accessRights | open access | |
| dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | |
| dc.subject | Traumatic brain injury | |
| dc.subject | Biomarkers | |
| dc.subject | Neuron-specific enolase | |
| dc.subject | S100B protein | |
| dc.subject | Prognosis | |
| dc.subject | Extracranial injury | |
| dc.subject.decs | Traumatismo craneoencefálico | |
| dc.subject.decs | Biomarcadores biológicos | |
| dc.subject.decs | Enolasa específica de neuronas | |
| dc.subject.decs | Proteína S100B | |
| dc.subject.decs | Pronóstico | |
| dc.subject.decs | Lesiones extracraneales | |
| dc.subject.mesh | Biomarkers | |
| dc.subject.mesh | Brain Injuries, Traumatic | |
| dc.subject.mesh | Humans | |
| dc.title | The utility of biomarkers in traumatic brain injury clinical management. | |
| dc.type | letter | |
| dc.type.hasVersion | VoR | |
| dc.volume.number | 20 | |
| dspace.entity.type | Publication |
Files
Original bundle
1 - 1 of 1

